Dr. Michael Adjei-Poku, MD

Dr. Adjei-Poku practices at Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health.

Dr. Adjei-Poku's NPI, 1528050465, was assigned on August 17, 2005. Dr. Adjei-Poku graduated from University of Ghana Medical School in 1985. Dr. Adjei-Poku holds New Mexico license MD2020-1152.

Dr. Adjei-Poku's primary practice is Lovelace Medical Center, at 601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM 87102 in Bernalillo County. The practice phone is (505) 727-8000.

Dr. Adjei-Poku's primary practice is Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health. Dr. Adjei-Poku is also affiliated with Presbyterian Hospital. The medical group on file is Lovelace Medical Group. Dmand AI also links Dr. Adjei-Poku to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adjei-Poku practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Adjei-Poku's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Adjei-Poku is board certified in adult congenital heart disease by the American Board of Internal Medicine. Dmand AI has Dr. Adjei-Poku's licenses on file in 5 states: New Mexico, New York, Pennsylvania, Utah and Rhode Island.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT), endocarditis and heart blockage among the conditions Dr. Adjei-Poku treats.

CMS data shows 2,223 Medicare services from Dr. Adjei-Poku across 19 procedure codes in 2024, for 1,060 Medicare patients. Medicare paid $104,003 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,060 Medicare patients who saw Dr. Adjei-Poku in 2024. The largest group is 65 to 74, with 430 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adjei-Poku's median patient age at 75, with 48% women.

In 2024, Dr. Adjei-Poku wrote 2,462 Medicare Part D claims for 421 patients. 82% of them were for generic drugs. CMS names the drug for 2,209 of them, across 34 drugs with 11 or more claims each, at $807,867 in total drug cost. In 2023, CMS named 2,023 claims across 32 drugs.

Dr. Adjei-Poku accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Adjei-Poku in 2024. Dr. Adjei-Poku's most frequent co-authors are Najib Michael Alturk, MD, Anne R. Cappola, MD and Ari B. Friedman, MD, PhD.

CMS Open Payments shows 35 general payments to Dr. Adjei-Poku from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Edwards Lifesciences Corporation paid the most, $145.

Dmand AI lists 2 awards for Dr. Adjei-Poku, most recently ACC Fellow in 2013.

Dr. Adjei-Poku graduated from University of Ghana Medical School in 1985. Dr. Adjei-Poku is a member of ACC and ACP.

Dr. Adjei-Poku is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.